Skip to content

Advancements in Stroke Recovery: The Role of Neural Stem Cells

Advancements in Stroke Recovery: The Role of Neural Stem Cells

Stroke represents a major health challenge, with nearly a quarter of adults experiencing a stroke in their lifetime, leaving almost half with permanent damage such as paralysis or speech disorders. Due to the damage inflicted on neurons by internal bleeding or lack of oxygen, there are currently no effective treatments to repair these damages. This underscores the importance of researching new therapeutic methods to regenerate the brain following diseases or injuries.

The Potential of Neural Stem Cells

Recent studies led by Christian Tackenberg from the Neuroscience Group at the University of Zurich have shown that neural stem cells have the potential to regenerate brain tissue. Research conducted in collaboration with the University of Southern California demonstrated that stem cells not only form new neurons but also stimulate other regenerative processes.

These studies relied on human neural stem cells derived from induced pluripotent stem cells, which can be manufactured from ordinary human somatic cells. Stroke was induced in genetically modified mice that do not reject human stem cells, and researchers monitored the condition’s progression using imaging techniques and biochemical analysis.

Promising Results in Brain Regeneration

Researchers found that the stem cells survived throughout the five-week analysis period, with most transforming into neurons that communicated with existing brain cells. Additionally, they observed new blood vessel formation, improved inflammatory response, and integrity of the blood-brain barrier.

Stem cell transplants in mice also reversed motor disturbances caused by stroke, as partially verified through AI-assisted gait analysis.

Clinical Applications: A Step Towards Reality

From the outset, Tackenberg aimed to apply these studies clinically to humans. Therefore, the stem cells were produced without using animal-derived materials, in collaboration with the Center for iPS Cell Research and Application at Kyoto University. This procedure is essential for future therapeutic applications in humans.

The studies also showed that stem cell transplantation is more effective when performed a week after a stroke, rather than immediately, which could significantly ease therapeutic preparation and execution.

Conclusion

Despite the encouraging study results, Tackenberg notes that work is ongoing to reduce risks and simplify potential human applications. Efforts are currently focused on developing a safety system to prevent uncontrolled stem cell growth in the brain, and exploring the possibility of delivering stem cells through intra-arterial injections, which would be more practical than brain transplants. If successful, stroke could be among the next conditions to undergo clinical trials.